Munich Reinsurance Co Stock Corp in Munich Has $18.28 Million Position in Lam Research Corporation $LRCX

Munich Reinsurance Co Stock Corp in Munich lessened its holdings in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 10.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 42,175 shares of the semiconductor company’s stock after selling 4,976 shares during the quarter. Munich Reinsurance Co Stock Corp in Munich’s holdings in Lam Research were worth $18,276,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. Fideuram Asset Management Ireland dac purchased a new stake in Lam Research in the 4th quarter valued at $10,035,000. Rokos Capital Management LLP grew its stake in shares of Lam Research by 42.0% in the 1st quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock worth $55,532,000 after acquiring an additional 76,840 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super purchased a new stake in shares of Lam Research in the first quarter valued at about $59,973,000. Y Intercept Hong Kong Ltd bought a new position in shares of Lam Research during the first quarter valued at about $26,489,000. Finally, Krilogy Financial LLC grew its position in Lam Research by 19.5% in the 1st quarter. Krilogy Financial LLC now owns 28,111 shares of the semiconductor company’s stock worth $6,006,000 after purchasing an additional 4,584 shares in the last quarter. 84.61% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Lam Research news, Director Eric Brandt sold 54,500 shares of the business’s stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the sale, the director owned 199,205 shares of the company’s stock, valued at $69,881,114. The trade was a 21.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $302.46, for a total value of $1,512,300.00. Following the sale, the insider owned 42,462 shares in the company, valued at approximately $12,843,056.52. This represents a 10.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 77,782 shares of company stock valued at $26,755,370. Company insiders own 0.31% of the company’s stock.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
  • Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
  • Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
  • Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
  • Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
  • Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
  • Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Lam Research Stock Up 5.1%

LRCX stock opened at $307.65 on Friday. The stock has a fifty day moving average of $321.34 and a 200-day moving average of $291.39. Lam Research Corporation has a fifty-two week low of $100.68 and a fifty-two week high of $438.50. The company has a market capitalization of $384.97 billion, a price-to-earnings ratio of 53.41, a PEG ratio of 1.16 and a beta of 1.85. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.13. The business had revenue of $6.72 billion for the quarter, compared to analysts’ expectations of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm’s quarterly revenue was up 30.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, equities research analysts predict that Lam Research Corporation will post 9.33 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Wednesday, September 23rd. This is an increase from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s dividend payout ratio is currently 18.06%.

Wall Street Analyst Weigh In

A number of analysts recently commented on LRCX shares. Oppenheimer reaffirmed an “outperform” rating and set a $400.00 price target (up from $330.00) on shares of Lam Research in a research report on Monday, June 15th. Susquehanna reaffirmed a “positive” rating and set a $475.00 target price (up from $385.00) on shares of Lam Research in a research report on Tuesday, June 30th. Wall Street Zen downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a report on Sunday, May 10th. Cantor Fitzgerald set a $500.00 price target on shares of Lam Research and gave the company an “overweight” rating in a research report on Monday, June 29th. Finally, Mizuho decreased their price objective on shares of Lam Research from $370.00 to $365.00 and set an “outperform” rating for the company in a report on Tuesday, August 25th. One analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Lam Research has an average rating of “Moderate Buy” and a consensus target price of $358.97.

Get Our Latest Report on LRCX

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

See Also

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.